Evidence map›Paper›PMID 20080757›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2010

The RNF8/RNF168 ubiquitin ligase cascade facilitates class switch recombination.

Shaliny Ramachandran, Richard Chahwan, Rajeev M Nepal, Darina Frieder, Stephanie Panier, Sergio Roa, Ahmad Zaheen, Daniel Durocher, Matthew D Scharff, Alberto Martin

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 81 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Shaliny RamachandranDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada.
Richard Chahwan
Rajeev M Nepal
Darina Frieder
Stephanie Panier
Sergio Roa
Ahmad Zaheen
Daniel Durocher
Matthew D Scharff
Alberto Martin
University of Toronto · CAAlbert Einstein College of Medicine · USMount Sinai Hospital · CAYeshiva University · US

Funding

SOMATIC MUTATION OF IG VARIABLE REGIONSR01CA072649 · NCI · YESHIVA UNIVERSITY · PI SCHARFF, MATTHEW D · 1997 to 2014
$5.0M
Mismatch repair in V region mutation and isotype switchingR01CA102705 · NCI · YESHIVA UNIVERSITY · PI SCHARFF, MATTHEW D · 2003 to 2013
$3.2M
CIHR MOP10703115CIHR MOP66965NCI NIH HHS R01 CA072649NCI NIH HHS R01 CA102705NCI NIH HHS R01CA102705NCI NIH HHS R01CA72649
6 · The paper itself

Abstract

An effective immune response requires B cells to produce several classes of antibodies through the process of class switch recombination (CSR). Activation-induced cytidine deaminase initiates CSR by deaminating deoxycytidines at switch regions within the Ig locus. This activity leads to double-stranded DNA break formation at the donor and recipient switch regions that are subsequently synapsed and ligated in a 53BP1-dependent process that remains poorly understood. The DNA damage response E3 ubiquitin ligases RNF8 and RNF168 were recently shown to facilitate recruitment of 53BP1 to sites of DNA damage. Here we show that the ubiquitination pathway mediated by RNF8 and RNF168 plays an integral part in CSR. Using the CH12F3-2 mouse B cell line that undergoes CSR to IgA at high rates, we demonstrate that knockdown of RNF8, RNF168, and 53BP1 leads to a significant decrease in CSR. We also show that 53BP1-deficient CH12F3-2 cells are protected from apoptosis mediated by the MDM2 inhibitor Nutlin-3. In contrast, deficiency in either E3 ubiquitin ligase does not protect cells from Nutlin-3-mediated apoptosis, indicating that RNF8 and RNF168 do not regulate all functions of 53BP1.

Indexed as

Recombination, GeneticAnimalsCell LineCytidine DeaminaseDNA-Binding ProteinsHumansImmunoglobulin AIntracellular Signaling Peptides and ProteinsMiceReverse Transcriptase Polymerase Chain ReactionTumor Suppressor p53-Binding Protein 1UbiquitinationUbiquitin-Protein LigasesCytidine DeaminaseDNA-Binding ProteinsImmunoglobulin AIntracellular Signaling Peptides and ProteinsRNF168 protein, humanRNF8 protein, humanTP53BP1 protein, humanTumor Suppressor p53-Binding Protein 1Ubiquitin-Protein Ligases

Identifiers

PMID20080757
PMCPMC2818930
OpenAlexW2059183599

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.